Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN23328456
ISRCTN23328456
Completed
未知

A prospective study for the effects of treatment with adalimumab in patients with psoriasis and psoriatic arthritis

Academic Medical Center (AMC) (Netherlands)0 sites24 target enrollmentJanuary 16, 2007
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsPsoriatic arthritis, psoriasisSkin and Connective Tissue DiseasesPsoriasis

Overview

Phase
未知
Intervention
Not specified
Conditions
Psoriatic arthritis, psoriasis
Sponsor
Academic Medical Center (AMC) (Netherlands)
Enrollment
24
Status
Completed
Last Updated
9 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 16, 2007
End Date
TBD
Last Updated
9 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Academic Medical Center (AMC) (Netherlands)

Eligibility Criteria

Inclusion Criteria

  • •1\. Patients with psoriatic arthritis and psoriasis
  • •2\. Age 18 to 80 years
  • •3\. At least two painful and two swollen joints
  • •4\. Inadequate respons to Non\-Steroidal Anti\-Inflammatory Drugs (NSAIDs)
  • •5\. Effective contraception
  • •6\. Signed informed consent

Exclusion Criteria

  • •1\. Use of another Disease Modifying Anti\-Rheumatic Drugs (DMARD) than methotrexate within four weeks of baseline
  • •2\. Intra\-articular injection with corticosteroids within four weeks of baseline
  • •3\. Other Tumour Necrotising Factor (TNF)\-blocking treatment or treatment with another biological agent within two months of baseline
  • •4\. Another skin or connective tissue disease that interferes with the assessment of psoriasis or psoriatic arthritis
  • •5\. Active or latent tuberculosis
  • •6\. Infection with Human Immunodeficiency Virus (HIV), hepatitis B or hepatitis C virus
  • •7\. Severe comorbidity
  • •8\. Malignancy other than basal cell carcinoma of skin within ten years of baseline
  • •9\. Pregnancy or breastfeeding

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
An Exploratory Study of the Effect of Treatment Interruption on Safety of Exenatide in Patients with Type 2 Diabetes - NDType 2 diabetesMedDRA version: 9.1Level: LLTClassification code 10049746Term: Insulin-requiring type II diabetes mellitus
EUCTR2006-006149-15-ITEli lilly and Company53
Completed
Not Applicable
ongitudinal study about the impact of treatment with tumor necrosis factor (TNF) inhibitors on tuberculin skin test (TST) reaction in patients with rheumatoid arthritis (RA).Rheumatoid arthritis (RA)
JPRN-UMIN000021048Jichi Medical University100
Not yet recruiting
Phase 3
An interventional study to access the effect of Homoeopathic medicine Arsenicum album 30 C as a prohylaxis in high risk population exposed to COVID-19.
CTRI/2020/06/026056Ministry of AYUSH
Active, not recruiting
Not Applicable
Effects on Respiratory Compliance with Sugammadex in Children on Ventilatio
JPRN-jRCTs041220060Yagihara Masahiro55
Not yet recruiting
Phase 3
An interventional study to access the effect of Ayurvedic medicine ASA-20 as a prohylaxis in high risk population exposed to COVID-19
CTRI/2020/06/026055Ministry of AYUSH